rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ANGO
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      AngioDynamics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      LATHAM, N.Y., November 06, 2026--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the grant of inducement awards to Eric Honroth in connection with his appointment as Chief Executive Officer of the Company effective as of November 2, 2026.

      Nov 6Yahoo FinanceANGO
      AngioDynamics to Participate in Upcoming Investor Conferences
      Oct 29Yahoo FinanceANGO
      AngioDynamics study shows survival benefit for pancreatic cancer
      Oct 21Investing.comANGO
      AngioDynamics Announces Publication of DIRECT Study Results and New Category I CPT Code for Pancreatic IRE
      Oct 21Yahoo FinanceANGO
      AngioDynamics: Progress Evident, But Volatility And Margin Concerns Persist (NASDAQ:ANGO)
      Oct 15Seeking AlphaANGO
      H.C. Wainwright cuts AngioDynamics stock price target to $18
      Oct 14Investing.comANGO
      AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife® IRE for Prostate and Liver Cancer
      Oct 14Yahoo FinanceANGOHUM
      Analysts Offer Insights on Healthcare Companies: AngioDynamics (ANGO), Neurocrine (NBIX) and DENTSPLY SIRONA (XRAY)

      Detailed price information for Angiodynamics Inc (ANGO-Q) from The Globe and Mail including charting and trades.

      Oct 10The Globe and MailANGONBIXXRAY
      Canaccord reiterates AngioDynamics stock rating on growth platforms
      Oct 9Investing.comANGO
      AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript

      Motley Fool Press Release.

      Oct 9The Globe and MailANGO
      AngioDynamics Inc (ANGO) (Q1 2027) Earnings Call Highlights: MedTech Momentum Drives 6. ...
      Oct 8Yahoo FinanceANGO
      AngioDynamics Stock Is Falling Thursday: What's Going On? - AngioDynamics (NASDAQ:ANGO)

      ANGO stock drops 21% as AngioDynamics reports Q1 results, names Eric Honroth as new CEO, and reaffirms FY27 guidance.

      Oct 8BenzingaANGO
      AngioDynamics, Inc. Q1 2027 Earnings Call Summary
      Oct 8Yahoo FinanceANGO
      Why AngioDynamics Crashed Today
      Oct 8Yahoo FinanceANGO
      AngioDynamics Q1 Earnings Call Highlights
      Oct 8Yahoo FinanceANGO
      AngioDynamics Q1 FY 2027 slides: Med Tech growth accelerates to 13%
      Oct 8Investing.comANGO
      AngioDynamics Q1 2027 Earnings Call: Complete Transcript - AngioDynamics (NASDAQ:ANGO)

      AngioDynamics (NASDAQ:ANGO) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga

      Oct 8BenzingaANGO
      Earnings call transcript: AngioDynamics beats Q1 2026 forecasts as shares fall premarket
      Oct 8Investing.comANGO
      AngioDynamics Shares Fall 4.3% Despite Q1 Earnings Beat and Strong Med Tech Growth
      Oct 8Yahoo FinanceANGO
      AngioDynamics earnings beat by $0.07, revenue topped estimates
      Oct 8Investing.comANGO
      Why is AngioDynamics stock sliding today?
      Oct 8Investing.comANGO
      AngioDynamics stock slips 4% despite beating estimates on Med Tech growth
      Oct 8Investing.comANGO
      AngioDynamics names Eric Honroth as new CEO, effective Nov. 2
      Oct 8Investing.comANGO
      AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
      Oct 8Yahoo FinanceANGO
      AngioDynamics: Fiscal Q1 Earnings Snapshot
      Oct 8Yahoo FinanceANGO
      AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability
      Oct 8Yahoo FinanceANGO
      AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer
      Oct 8Yahoo FinanceANGO
      AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence
      Oct 2Yahoo FinanceANGO
      AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026

      LATHAM, N.Y., September 28, 2026--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the first quarter of fiscal year 2027 before the market open on Thursday, October 8, 2026. The Company’s management will host a conference call at 8:00 am ET the same day to discuss the results.

      Sep 28Yahoo FinanceANGO

      This is the newest page. Registered accounts read further back.